当前位置： SCI文献检索 > JOURNAL OF MEDICAL ECONOMICS期刊下所有文献 > Costs of managing severe hypoglycaemia in three European countries.

Costs of managing severe hypoglycaemia in three European countries.

Abstract：

OBJECTIVES:To assess the costs of severe hypoglycaemic events (SHEs) in diabetes patients in Germany, Spain and the UK. METHODS:Healthcare resource use was measured by surveying 639 patients aged ≥ 16 years, receiving insulin for type 1 (n=319) or type 2 diabetes (n=320), who experienced ≥ 1 SHE in the preceding year. Patients were grouped by location of SHE treatment: group 1, community (family/domestic); group 2, community (healthcare professional); group 3, hospital. Costs were calculated from published unit costs applied to estimated resource use. Costs per SHE were derived from patient numbers per subgroup. Weighted average costs were derived using a prevalence database. RESULTS:Hospital treatment was a major cost in all countries. In Germany and Spain, costs per SHE for type 1 patients differed from those for type 2 patients in each group. Average SHE treatment costs were higher for patients with type 2 diabetes (Germany, €533; Spain, €691; UK, €537) than type 1 diabetes patients (€441, €577 and €236, respectively). Telephone calls, visits to doctors, blood glucose monitoring and patient education contributed substantially to costs for non-hospitalised patients. CONCLUSIONS:Treatment of SHEs adds significantly to healthcare costs. Average costs were lower for type 1 than for insulin-treated type 2 diabetes, in all three countries.

journal_name

J Med Econ

journal_title

Journal of medical economics

authors

Hammer M,Lammert M,Mejías SM,Kern W,Frier BM

doi

10.3111/13696990903336597

subject

Has Abstract

pub_date

2009-01-01 00:00:00

pages

281-90

issue

4

eissn

1369-6998

issn

1941-837X

journal_volume

12

pub_type

杂志文章

相关文献

JOURNAL OF MEDICAL ECONOMICS文献大全